Harm Reduction Group Q2 2023: Clouds gather on Norway’s vaping horizon - Redeye

Redeye trims its valuation range after reviewing Harm Reduction Group’s Q2 2023 report. Weak B2C sales for the quarter and concerns about a potential flavour ban in Norway’s vaping market contribute to a lowered valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/940951/harm-reduction-group-q2-2023-clouds-gather-on-norways-vaping-horizon?utm_source=finwire&utm_medium=RSS